<DOC>
<DOCNO>
EP-0000526
</DOCNO>
<TEXT>
<DATE>
19790207
</DATE>
<IPC-CLASSIFICATIONS>
<main>A61K-31/43</main> A61P-31/00 A61K-31/545 A61K-31/43 A61K-31/42 A61K-31/429 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical preparations containing penicillins or cephalosporins and clavulanic acid; process for their preparation.
</TITLE>
<APPLICANT>
bayer agde<sep>bayer aktiengesellschaft<sep>bayer ag51368 leverkusende <sep>bayer ag<sep>
</APPLICANT>
<INVENTOR>
feyen peter dr<sep>konig hans-bodo dr  <sep>metzger karl georg dr<sep>preiss michael dr<sep>schrock wilfried dr<sep>feyen, peter, dr.<sep>konig, hans-bodo, dr.<sep>metzger, karl georg, dr.<sep>preiss, michael, dr.<sep>schrock, wilfried, dr.<sep>feyen, peter, dr.mozartstrasse 1d-4020 mettmannde<sep>könig, hans-bodo, dr.herberts katernberg 10d-5600 wuppertal 1de<sep>metzger, karl georg, dr.pahlkestrasse 15d-5600 wuppertal 1de<sep>preiss, michael, dr.egenstrasse 21d-5600 wuppertal 1de<sep>schröck, wilfried, dr.pahlkestrasse 33d-5600 wuppertal 1de<sep>feyen, peter, dr.<sep>konig, hans-bodo, dr.<sep>metzger, karl georg, dr.<sep>preiss, michael, dr. <sep>schrock, wilfried, dr.  <sep>feyen, peter, dr.mozartstrasse 1d-4020 mettmannde<sep>könig, hans-bodo, dr.herberts katernberg 10d-5600 wuppertal 1de<sep>metzger, karl georg, dr.pahlkestrasse 15d-5600 wuppertal 1de<sep>preiss, michael, dr.egenstrasse 21d-5600 wuppertal 1de<sep>schröck, wilfried, dr.pahlkestrasse 33d-5600 wuppertal 1de<sep>
</INVENTOR>
<ABSTRACT>
1.  an antibiotic composition, characterised in that it contains an active compound combination consisting of (1) beta-lactam antibiotics of the formula i :  see diagramm : ep0000526,p9,f1  in which r1 represents  see diagramm : ep0000526,p9,f2   see diagramm : ep0000526,p9,f3   see diagramm : ep0000526,p9,f4   see diagramm : ep0000526,p9,f5   see diagramm : ep0000526,p9,f6  and  see diagramm : ep0000526,p9,f7  r2 represents phenyl, p-hydroxyphenyl or furyl, r3 represents h, och3 or oc2 h5 and wherein y denotes  see diagramm : ep0000526,p9,f8  or  see diagramm : ep0000526,p9,f9  wherein t represents -o-co-ch3 , -o-co-nh2 ,  see diagramm : ep0000526,p9,f10 see diagramm : ep0000526,p9,f11  or  see diagramm : ep0000526,p9,f12 and r4 is h, ch3 , -ch2 -cooh, -ch2 -so3 h or -ch2 -ch2 -n(ch3 )2 or their pharmaceutically usable salts, in particular the sodium salts, or their various crystal or hydrate forms and (2) clavulanic acid of the formula ii  see diagramm : ep0000526,p9,f13  or its pharmaceutically usable salts or esters which can be split vivo, in particular its sodium salt. 
</ABSTRACT>
</TEXT>
</DOC>
